Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients

V. Bironneau, E. Antone, P. Ingrand, J. Paquereau, J. C. Meurice (Poitiers, France)

Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Session: A metabolic medley: sleep disordered breathing
Session type: Thematic Poster Session
Number: 2540
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Bironneau, E. Antone, P. Ingrand, J. Paquereau, J. C. Meurice (Poitiers, France). Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients. Eur Respir J 2013; 42: Suppl. 57, 2540

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of metabolic syndrome (MS) in a population of apneic patients:A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Elevated risk of motor vehicle accidents in patients with obstructive sleep apnea syndrome: A case-control study
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Prevalence of obstructive sleep apnea syndrome in patients with risk factors for cardiovascular diseases in a large population in Zaragoza (Spain)
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


Sleep disordered breathing in patients with cardiovascular comorbidities hospitalized for pulmonary disease
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment
Source: Eur Respir J 2002; 20: 1511-1518
Year: 2002



Severe obstructive sleep apnea syndrome in elderly population: A prospective study of 80 patients
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015

Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome
Source: Annual Congress 2013 –Sleep disordered breathing in special situations II
Year: 2013


Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013

Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC)
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016


LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Dietary treatment outcomes of mild obstructive sleep apnea in obese community-dwelling children: The NANOS study
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

Obesity and chronic intermittent hypoxia are independent risk factors for clinical decompensation in patients with cirrhosis and OSAS
Source: International Congress 2014 – Inflammation and obesity: implications for OSA
Year: 2014